search
drug discovery
Trends
- 1Roche lays out plans for autonomous AI-driven laboratories▼Roche outlines plans to move towards autonomous AI labs
Roche has outlined plans to move towards autonomous laboratories powered by artificial intelligence, where research experiments could be designed, run and analysed with minimal human involvement. The Swiss pharmaceutical group's roadmap points to AI systems handling much of the drug discovery workflow. Details of timelines and investment were limited in the initial reporting, leaving analysts awaiting specifics.
- 2Basecamp Research raises $140M to map biodiversity with AI●UK-based Basecamp Research raised $140M to map global biodiversity for drug discovery. By training AI on genetic data fr
UK-based Basecamp Research has raised $140 million to map global biodiversity for drug discovery. The company trains AI on genetic data from unexplored organisms to help design new therapies. Commenters note that scaling the work will depend on proving safety in human trials and ensuring fair benefit-sharing with the countries and communities where genetic material originates.
- 3AI's biggest payoff could be better medicines●The AI boom’s biggest payoff could be better medicines
Commentators argue that the clearest real-world benefit of the current AI boom may come in medicine, where artificial intelligence can speed up drug discovery, identify promising compounds, and shorten the path from lab research to approved treatments. The claim suggests that beyond consumer chatbots and productivity tools, healthcare and pharmaceuticals could be where AI delivers its most valuable results for society.